Estimating the Full Value of High-Dose Influenza Vaccine

J Am Geriatr Soc. 2017 Sep;65(9):2110-2111. doi: 10.1111/jgs.14950. Epub 2017 Jun 6.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adult
  • Aged
  • Cost-Benefit Analysis
  • Humans
  • Influenza Vaccines*
  • Influenza, Human*
  • Public Health

Substances

  • Influenza Vaccines